Bcl-xL is frequently overexpressed in lung tumors, is associated with poor prognosis [16], [17] and plays an important role in resistance to genotoxic chemotherapeutic agents in lung and other cancer types [18], [19], [20], [21], [22], [23]. This evidence concerns the gene BCL2L1 and cancer.